About Songklanagarind Hospital; Department of Internal Medicine, Division of Respiratory
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
7
Clinical Trials at Songklanagarind Hospital; Department of Internal Medicine, Division of Respiratory
During the past decade, Songklanagarind Hospital; Department of Internal Medicine, Division of Respiratory conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on
average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Tarceva (Erlotinib) as First Line Therapy in Participants With Non-Small Cell Lung Cancer Harbouring Epidermal Growth Factor Receptor (EGFR) Mutations
2011-04-30
2016-12-30
Completed
208
A Study Comparing Alectinib With Crizotinib in Treatment-Naive Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer Participants
2014-08-19
2026-09-29
Active, not recruiting
303
A Study to Evaluate and Compare the Efficacy and Safety of Alectinib Versus Crizotinib and to Evaluate the Pharmacokinetics of Alectinib in Asian Participants With Treatment-Naive Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small Cell Lung Cancer (NSCLC)
2016-08-03
2019-12-06
Unknown status
187
A Study of Tiragolumab in Combination With Atezolizumab Compared With Placebo in Combination With Atezolizumab in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1-Selected Non-Small Cell Lung Cancer
2020-03-04
2025-02-21
Recruiting
660
A Study of Atezolizumab and Tiragolumab Compared With Durvalumab in Participants With Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC)
2020-08-24
2027-12-30
Active, not recruiting
800
A Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of Participants With Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer (NSCLC)
2022-11-01
2035-04-14
Recruiting
320
Screening Study for Participants With Malignant Tumors
2022-07-22
2032-12-22
Recruiting
15,000
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Songklanagarind Hospital; Department of Internal Medicine, Division of Respiratory
According to Clinical.Site data, the most researched conditions in "Songklanagarind Hospital; Department of Internal Medicine, Division of Respiratory" are
"Non-Small Cell Lung Cancer" (3 trials), "Anaplastic Lymphoma Kinase-positive Non-small Cell Lung Cancer" (1 trials), "Non-Squamous Non-Small Cell Lung Cancer" (1 trials), "Non-small Cell Lung Cancer (NSCLC)" (1 trials) and "Solid Tumors" (1 trials). Many other conditions were trialed in "Songklanagarind Hospital; Department of Internal Medicine, Division of Respiratory" in a lesser frequency.
Clinical Trials Intervention Types at Songklanagarind Hospital; Department of Internal Medicine, Division of Respiratory
Most popular intervention types in "Songklanagarind Hospital; Department of Internal Medicine, Division of Respiratory" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Alectinib" (3 trials), "Atezolizumab" (2 trials), "Crizotinib" (2 trials), "Durvalumab" (2 trials) and "Tiragolumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Songklanagarind Hospital; Department of Internal Medicine, Division of Respiratory
The vast majority of trials in "Songklanagarind Hospital; Department of Internal Medicine, Division of Respiratory" are
7 trials for "All" genders.
Clinical Trials Status at Songklanagarind Hospital; Department of Internal Medicine, Division of Respiratory
Currently, there are NaN active trials in "Songklanagarind Hospital; Department of Internal Medicine, Division of Respiratory".
undefined are not yet recruiting,
3 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Songklanagarind Hospital; Department of Internal Medicine, Division of Respiratory,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Songklanagarind Hospital; Department of Internal Medicine, Division of Respiratory, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".